What Is a Cardiovascular Clinical Trial and How Do They Work?

Cardiovascular disease remains the leading cause of death in the United States. Clinical trials are the structured way that new treatments — from medications and biologics to implantable devices and minimally invasive procedures — are studied in people before they become standard care.

What is a cardiovascular clinical trial?

A cardiovascular clinical trial is a research study designed to evaluate whether a new therapy is safe and effective in people with heart or vascular disease. It follows a detailed written plan called a protocol that defines who can participate, what tests are performed, how outcomes are measured, and how safety is monitored.

• Drug therapies for conditions such as heart failure, hypertension, or acute coronary syndrome
• Medical devices including stents, valves, and atherectomy systems
• Diagnostic tools such as imaging or blood-based biomarkers
• Procedural techniques such as transcatheter valve replacement

How are clinical trials regulated?

In the United States, clinical trials are regulated by the U.S. Food and Drug Administration (FDA) and reviewed by an Institutional Review Board (IRB) before any participant is enrolled. Studies follow ICH Good Clinical Practice (GCP) — an international ethical and scientific quality standard.

Every interventional trial conducted in the U.S. must be registered on ClinicalTrials.gov, where the public can view its protocol summary, eligibility criteria, locations, and results when available.

How are participants protected?

1. Informed consent: participants receive a written document describing the study, risks, benefits, and alternatives, and have time to ask questions before signing.
2. IRB oversight: an independent ethics committee reviews and approves the protocol and any amendments.
3. Investigator qualifications: trials are led by a Principal Investigator with relevant clinical and research training.
4. Ongoing safety monitoring: adverse events are reported to the sponsor, IRB, and (when required) the FDA.
5. The right to withdraw at any time, for any reason, without affecting future medical care.

What are the phases of a clinical trial?

Drug and device studies are typically organized into phases, each designed to answer specific questions. We cover the differences in detail in our companion article on clinical trial phases.

Who runs cardiovascular clinical trials?

Trials are typically initiated by a sponsor (often a pharmaceutical company, device manufacturer, or academic group), conducted at qualified sites under a Principal Investigator, and supported by a Clinical Research Organization (CRO) that helps with monitoring and data management. At Amavita Research, our Principal Investigator and Chief Medical Officer team brings decades of interventional cardiology and clinical-trial leadership to every protocol we run.

How can I find a cardiovascular clinical trial?

You can search ClinicalTrials.gov by condition, location, and recruitment status. You can also speak with your cardiologist, or contact a dedicated research site such as Amavita Research to learn what is currently enrolling in Miami.